Finding Providers

We found 3 mohs skin cancer surgeons who accept Amerigroup near Brooklyn, NY.

Showing 1-3 of 3
Dr. Ritu Saini, MD
Specializes in MOHS-Micrographic Surgery
423 East 23rd Street
New York, NY

Dr. Ritu Saini is a mohs skin cancer surgeon in New York, NY, Queens, NY, and Rockaway Park, NY. Her areas of expertise include the following: hair problems, rosacea, and acne. Patients gave Dr. Saini an average rating of 4.0 stars out of 5. Blue Cross/Blue Shield, Aetna Medicare, and Vytra are among the insurance carriers that Dr. Saini accepts. Dr. Saini graduated from New York University (NYU) School of Medicine. For her professional training, Dr. Saini completed a residency program at a hospital affiliated with the University of Miami. Her distinctions include: New York Super Doctors and New York Rising Stars. Her professional affiliations include VA NY Harbor Healthcare System and NYU Langone Medical Center.

Read more

Clinical interests: Eczema, Sclerotherapy, Cosmetic Surgery, Skin Cancer, Hair Problems, Rosacea, Laser Surgery, Mohs ... (Read more)

No Photo
Specializes in MOHS-Micrographic Surgery
161 6th Avenue; Suite 1304
New York, NY

Dr. Michael Shapiro is a MOHS-micrographic surgery specialist. Patient reviews placed him at an average of 4.0 stars out of 5. Dr. Shapiro is professionally affiliated with NewYork-Presbyterian Queens. He is an in-network provider for Amerigroup, Child Health Plus, and Family Health Plus, as well as other insurance carriers. New patients are welcome to contact his office for an appointment. He graduated from the University of Pennsylvania School of Medicine. Dr. Shapiro's residency was performed at a hospital affiliated with the University of Pennsylvania. Dr. Shapiro (or staff) is conversant in Spanish and Russian.

Read more
Dr. Steven M Weissman, MD
Specializes in MOHS-Micrographic Surgery
9413 Flatlands Avenue; Suite 102 East
Brooklyn, NY

Dr. Steven Weissman is a MOHS-micrographic surgery specialist. Patients rated Dr. Weissman highly, giving him an average of 4.0 stars out of 5. He is an in-network provider for Amerigroup, Child Health Plus, and Blue Cross/Blue Shield, in addition to other insurance carriers. He attended medical school at Albert Einstein College of Medicine of Yeshiva University.

Read more

Conditions / Treatments



New Patients

Medicare Patient Conditions

Medicare Patient Ethnicity

Additional Information


Foreign Language


Online Communication

Practice Affiliation



Medical School


Years Since Graduation

What is MOHS-Micrographic Surgery?

Mohs micrographic surgery is a surgical treatment for skin cancer that was developed by Dr. Frederick Mohs in the 1930’s. It is the most effective technique for removing the most common types of skin cancer. For the two most common types of skin cancer, basal cell carcinoma and squamous cell carcinoma, Mohs has a 98-99% cure rate. The remarkable thing about Mohs is that it manages to be extremely good at removing all of the cancer cells while at the same time leaving behind most of the healthy tissue, so there is a smaller wound. This makes the procedure safer, speeds up the the recovery time, and minimizes scarring.

During Mohs surgery, skin around the cancer site is mapped out and removed in thin layers. Then each layer is examined under a microscope for cancer cells, while the surgery is in progress. If cancer cells are detected, the surgery continues and another layer is removed. If the skin is clear, the surgery can be stopped. This eliminates the guesswork for surgeons. There is no need to estimate the borders or roots of the cancer and no need to remove a margin of healthy tissue to ensure that all of the cancer is removed.

Even though Mohs has a high cure rate, is safer than other treatments, and takes less tissue, not every skin cancer is treated with Mohs. First, Mohs takes quite a bit longer than traditional surgery because each layer of skin must be carefully cut, prepped, and examined. It is also more expensive and may not always be covered by insurance. In addition, for smaller or less aggressive cancers that are easier to treat, the cure rate for non-Mohs treatments is close to that of Mohs; thus, the extra time and cost of Mohs might not be justified. Other kinds of skin cancer, such as melanoma, are hard to see under a microscope. Since melanoma is so dangerous, Mohs has traditionally not been used to treat it, as there is too much risk for missed cancer cells being left behind in the body. However, recent developments in stains (which make cancer cells more visible under a microscope) may change the role of Mohs in melanoma treatment.

Mohs microsurgery has changed the way doctors treat skin cancer in the past 80 years, and it continues to gain in popularity as it increases the effectiveness and safety of skin cancer treatment.